Clinical Trials on Asthma-Chronic+Obstructive+Pulmonary+Disease+Overlap+Syndrome

Total 13111 results

Novartis Pharmaceuticals

Completed

QVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) (ILLUMINATE)

Chronic Obstructive Pulmonary Disease (COPD)

Spain, Germany, Estonia, Hungary, Belgium, Czech Republic, Norway, Korea, Republic of, Lithuania
Minneapolis Veterans Affairs Medical Center

Completed

Effect of Supplemental Vitamin D on Skeletal Muscle Function in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease (COPD)

United States
Novartis

Completed

Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

France, Germany, Belgium, Spain, Turkey, Italy, Canada, Australia
GlaxoSmithKline

Completed

A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease)

Pulmonary Disease, Chronic Obstructive | Chronic Obstructive Pulmonary Disease (COPD)

Germany
Novartis

Completed

Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States, Spain, Turkey, France, Netherlands, Germany
VA Office of Research and Development

Terminated

Inhaled Fluticasone Effects on Upper Airway Patency in Obstructive Lung Disease (InFLOW)

Chronic Obstructive Pulmonary Disease | Asthma | Obstructive Sleep Apnea

United States
Chinese Academy of Medical Sciences, Fuwai Hospital

Unknown

Registry for Chronic Obstructive Pulmonary Disease With Sleep Apnea Hypopnea Syndrome in China

Sleep Apnea Syndromes | COPD

China
Mylan Inc.
Theravance Biopharma

Completed

A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD

Chronic Obstructive Pulmonary Disease (COPD)

United States
University Hospital, Ghent
GlaxoSmithKline; University Ghent

Completed

Pharmaceutical Care for Chronic Obstructive Pulmonary Disease (COPD) Study. (PHARMACOP)

Chronic Obstructive Pulmonary Disease (COPD)

Belgium
Optimum Patient Care
Respiratory Effectiveness Group; Boehringer Ingelheim Pharmaceutical Company... and other collaborators

Unknown

Advancing the Patient Experience in Chronic Obstructive Pulmonary Disease (APEX COPD) (APEX COPD)

Chronic Obstructive Pulmonary Disease (13645005)

United States
Poitiers University Hospital

Completed

Interest of Branched Chain Amino Acids Associated With a Respiratory Rehabilitation Program in Patients Broncho Chronic Obstructive Pulmonary Disease (REHABAAR)

Broncho Chronic Obstructive Pulmonary Disease

France
AstraZeneca

Completed

A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy

Chronic Obstructive Pulmonary Disease COPD

United States, Netherlands, Argentina, South Africa, Chile, Peru
Laval University
Maltais, Francois, M.D.; Saey, Didier, M.D.

Completed

Chen-style Tai Chi in Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

Canada
Sunovion Respiratory Development Inc.

Completed

A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-5)

Chronic Obstructive Pulmonary Disease (COPD)

United States, Czechia, Hungary, Russian Federation
University of Aarhus

Completed

Beetroot Juice - Effects on Performance in Chronic Obstructive Pulmonary Disease Patients (COPD)

Chronic Obstructive Pulmonary Disease Moderate

Denmark
AstraZeneca

Completed

Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease (COPD)

Germany, Czech Republic, France, Hungary, Italy, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
AstraZeneca

Completed

Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127) (EOS)

Chronic Obstructive Pulmonary Disease (COPD)

Austria, Belgium, Canada, France, Germany, Italy, Netherlands, South Africa, Spain, United Kingdom
AstraZeneca

Completed

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)

Chronic Obstructive Pulmonary Disease (COPD)

Germany, Spain, United States, Canada, India, Italy, Poland, South Africa
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)

Chronic Obstructive Pulmonary Disease (COPD)

Japan
Nuvaira, Inc.

Completed

Innovative Pulmonary Solutions (IPS) System for Targeted Lung Denervation (IPS-I)

Chronic Obstructive Pulmonary Disease (COPD)

Netherlands, South Africa
Novartis Pharmaceuticals

Completed

Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation

Chronic Obstructive Pulmonary Disease (COPD)

Colombia, India, Korea, Republic of, Poland, Croatia, Estonia, Hungary, United Kingdom, Israel, Latvia, Turkey, Argentina, Panama, Mexico, Russian Federation, Serbia, Slovenia
University Medical Center Groningen

Terminated

Respiratory EMG for NIV Titration in Stable COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)

Netherlands
University Hospital, Tours

Completed

Evaluation of Benefit of Nebulized Bronchodilators at Home in Severe Chronic Obstructive Pulmonary Disease and Very Severe Steady State (Nebuadom)

Severe Chronic Obstructive Pulmonary Disease

France
Air Liquide Santé International
ITEC Services; Lincoln Medical and Mental Health Center

Completed

The COPD Patient Management European Trial (COMET) (COMET)

Chronic Obstructive Pulmonary Disease (COPD)

France, Spain, Germany, Italy
Aveiro University
Fundação para a Ciência e a Tecnologia

Completed

Home-monitoring and Adherence of Patients With COPD to Long-term Rehabilitation

Chronic Obstructive Pulmonary Disease (COPD)

Portugal
Universidade Federal de Pernambuco
Conselho Nacional de Desenvolvimento Científico e Tecnológico

Unknown

Whole Body Vibration in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease (COPD)

Brazil
Air Force Military Medical University, China

Unknown

Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease Patients (BTCOPD)

Chronic Obstructive Pulmonary Disease (COPD)

China
Pulmatrix Inc.
Quotient Clinical

Completed

A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
University of Edinburgh
The Dunhill Medical Trust

Completed

HELPing Older People With Very Severe Chronic Obstructive Pulmonary Disease Towards the End of Their Lives: Developing, Piloting and Refining a Practical Intervention (HELP-COPD) (HELP-COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Universidade Federal de Sao Carlos

Completed

Physical Training and Heart Rate Variability in COPD

Chronic Obstructive Pulmonary Disease (COPD)

Brazil
Helse Stavanger HF

Completed

Readmissions to Hospital Among Patients With COPD After Telemedicine Video Consultation - a Pilot Project

Chronic Obstructive Pulmonary Disease (COPD)

Norway
Hospital de Mataró

Completed

Urban Walking Circuits

Severe Chronic Obstructive Pulmonary Disease

Spain
GlaxoSmithKline

Completed

Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive | Chronic Obstructive Pulmonary Disease (COPD)

Denmark, Germany, Netherlands, Finland, United Kingdom
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease (INTRUST2)

Chronic Obstructive Pulmonary Disease (COPD)

United States, Colombia, Spain, Canada, Slovakia, India, Netherlands, Czech Republic, Hungary
Novartis

Completed

Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control

Chronic Obstructive Pulmonary Disease (COPD)

Russian Federation, Germany, Denmark, Italy, Canada, Czech Republic, Hungary, India, Slovakia, France, Colombia, Finland, Taiwan, Iceland, Peru
Novartis Pharmaceuticals

Completed

Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Taiwan, Korea, Republic of, Japan, India, Hong Kong, Singapore
my mhealth Ltd
Portsmouth Hospitals NHS Trust

Completed

Trial of E-Health Platform Supported Care vs Usual Care After Exacerbation of COPD (RESCUE)

Chronic Obstructive Pulmonary Diseases

United Kingdom
Strados Labs, Inc.

Withdrawn

Utility of Remote Lung Auscultation in Transitions of Care After Pulmonary Exacerbations of COPD

Chronic Obstructive Pulmonary Disease (COPD)

United States
Pulmatrix Inc.

Completed

A Phase 1b Study of PUR1800 in Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Mylan Inc.
Theravance Biopharma

Completed

A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Mylan Inc.
Theravance Biopharma

Completed

Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Mylan Inc.
Theravance Biopharma

Completed

Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Chiesi Farmaceutici S.p.A.

Completed

Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD) (TRIVERSYTI)

COPD (Chronic Obstructive Pulmonary Disease)

China, Korea, Republic of, Taiwan
Hannover Medical School
CAPNETZ Stiftung

Completed

Study to Demonstrate That Antibiotics Are Not Needed in Moderate Acute Exacerbations of COPD

Chronic Obstructive Pulmonary Disease (COPD)

Germany
University of Aarhus

Completed

Tele Health Monitoring Service for Patients With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease, COPD

Denmark
Barcelona Institute for Global Health
KU Leuven; University Medical Center Groningen; University of Athens; University... and other collaborators

Completed

Non-interventional Cross-over Study to Reduce Items of PROactive Tools Measuring Physical Activity in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Netherlands, Greece, Belgium, United Kingdom
Novartis Pharmaceuticals

Withdrawn

Efficacy of Indacaterol 150 µg Versus Formoterol

Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals

Withdrawn

Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active Control (INITIATE)

Chronic Obstructive Pulmonary Disease (COPD)
Memorial Hospital of Rhode Island
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Translating The GOLD COPD Guidelines Into Primary Care Practice (LungAge)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Norwegian University of Science and Technology

Completed

Patient Education in Patients With Chronic Obstructive Pulmonary Disease (COPD) - Effect and Costs

Chronic Obstructive Pulmonary Disease (COPD)

Norway

Clinical Trials on Asthma-Chronic+Obstructive+Pulmonary+Disease+Overlap+Syndrome

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations